Exosomm Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Upcoming)

  • Investors
  • 10

Exosomm General Information

Description

Operator of nutraceutical ingredients intended to enhance cellular communication and support health through bioactive compounds. The company's platform offers milk-derived exosome-based formulations processed into shelf-stable powders for improved bioavailability and stability, enabling nutraceutical manufacturers and health-focused consumers to support digestive health and manage inflammation.

Contact Information

Website
www.exosomm.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Katzrin Industrial Area
  • Katzrin
  • Israel
Primary Industry
Food Products
Vertical(s)
Corporate Office
  • Katzrin Industrial Area
  • Katzrin
  • Israel

Exosomm Timeline

20232024202520262027
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exosomm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 01-Jan-2027 Upcoming Product Development
9. Later Stage VC 01-Feb-2026 Completed Product Development
8. Accelerator/Incubator Completed Product Development
7. Seed Round 20-Nov-2024 Completed Product Development
6. Accelerator/Incubator 12-May-2024 Completed Product Development
5. Accelerator/Incubator 03-May-2023 Completed Product Development
4. Accelerator/Incubator Completed Product Development
3. Grant 07-Apr-2023 Completed Product Development
2. Seed Round 01-Dec-2021 $1M $1M Completed Startup
1. Accelerator/Incubator 01-Jan-2021 Completed Startup
To view Exosomm’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Exosomm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exosomm Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Siddhi Capital Growth/Expansion Minority
SOSV Venture Capital Minority
HiCenter Accelerator/Incubator
AgFunder Venture Capital Minority
GROW Accelerator Accelerator/Incubator
You’re viewing 5 of 10 investors. Get the full list »

Exosomm FAQs

  • When was Exosomm founded?

    Exosomm was founded in 2021.

  • Where is Exosomm headquartered?

    Exosomm is headquartered in Katzrin, Israel.

  • What is the size of Exosomm?

    Exosomm has 4 total employees.

  • What industry is Exosomm in?

    Exosomm’s primary industry is Food Products.

  • Is Exosomm a private or public company?

    Exosomm is a Private company.

  • What is Exosomm’s current revenue?

    The current revenue for Exosomm is .

  • How much funding has Exosomm raised over time?

    Exosomm has raised $3.1M.

  • Who are Exosomm’s investors?

    Siddhi Capital, SOSV, HiCenter, AgFunder, and GROW Accelerator are 5 of 10 investors who have invested in Exosomm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process